READ MORE
READ MORE
READ MORE
BEVA Council member James Crabtree represented BEVA in discussions along with other equine industry representatives, over a strategy of how best to approach the 2024 breeding season in the face of the ongoing unavailability of Equip Artervac (Zoetis) and confirmation that the vaccine will be unavailable until at least the back end of 2024. Meetings involved Zoetis, DEFRA, members of the Eqiune Infectious Disease Surveilance (EIDS) team, BEVA and representatives of the Thoroughbred Breeding Indu